Valacyclovir Dosing for a 15-Year-Old
For a 15-year-old adolescent, valacyclovir dosing depends on the specific HSV indication, but generally follows adult dosing regimens since adolescents ≥12 years are treated as adults for most HSV infections.
Indication-Specific Dosing
Cold Sores (Herpes Labialis)
- 2 grams twice daily for 1 day (12 hours apart) 1
- Initiate at earliest symptom (tingling, itching, burning)
- This is FDA-approved for adolescents ≥12 years 1
Genital Herpes
First Episode:
- 1 gram twice daily for 7-10 days 2, 1
- Most effective when started within 48 hours of symptom onset
- May extend beyond 10 days if healing incomplete
Recurrent Episodes:
- 500 mg twice daily for 3-5 days 2, 1
- Initiate at first sign of prodrome or lesions
- Patient should have medication available for self-initiated therapy
Suppressive Therapy:
- 500 mg once daily for patients with ≤9 recurrences/year 2, 1
- 1000 mg once daily for patients with ≥10 recurrences/year 2
- Alternative: 500 mg twice daily (more effective for frequent recurrences)
Chickenpox (Varicella)
- 20 mg/kg three times daily for 5 days (maximum 1 gram per dose) 1
- FDA-approved for ages 2 to <18 years
- Initiate at earliest sign of rash
Herpes Zoster (Shingles)
- 1 gram three times daily for 7 days 1
- Start within 48-72 hours of rash onset for maximum efficacy
- While FDA-approved for adults, this dosing can be used in adolescents who can tolerate adult dosing
Key Clinical Considerations
Weight-Based Dosing Threshold
The 2009 CDC/NIH pediatric guidelines specify that children <45 kg should use acyclovir 20 mg/kg (max 400 mg/dose) three times daily rather than valacyclovir for genital herpes 3. However, the FDA label states valacyclovir is approved for adolescents ≥12 years at adult doses for cold sores 1.
For a typical 15-year-old ≥45 kg: Use adult valacyclovir dosing as outlined above.
For a 15-year-old <45 kg: Consider acyclovir instead, particularly for genital herpes, as pediatric data for valacyclovir in this weight range are limited 3.
Important Caveats
Renal Function: Valacyclovir requires dose adjustment for impaired renal function. Ensure adequate hydration and assess kidney function if concerns exist 1.
No Pediatric Liquid Formulation: The FDA label notes "no pediatric preparation exists" for valacyclovir 3. An extemporaneous suspension (25 or 50 mg/mL) can be compounded from 500-mg tablets if the adolescent cannot swallow pills 1.
HIV-Infected Adolescents: The guidelines note valacyclovir "is approved for use in adults and adolescents with mucocutaneous HSV at a dosage of 1 g orally twice daily" but emphasize limited pediatric dosing data 3.
Safety Profile
Valacyclovir is generally well-tolerated in adolescents. The most common adverse effects are headache and nausea, occurring in <10% of patients 4. Serious adverse events are rare in immunocompetent patients 2.
Resistance
Antiviral resistance remains rare (<0.5%) in immunocompetent patients, even with prolonged suppressive therapy 4. This should not influence initial treatment decisions in healthy adolescents.